Ionis Pharmaceuticals | IONS - Sales Revenues

Stock Price
74.20
Daily Change
-1.48 -1.96%
Monthly
-1.41%
Yearly
121.10%
Q2 Forecast
74.14

Ionis Pharmaceuticals reported $246M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Agios Pharmaceuticals USD 18.8M 1.17M Mar/2026
Alnylam Pharmaceuticals USD 1.17B 70M Mar/2026
Arrowhead Research USD 73.74M 190.29M Mar/2026
Astellas Pharma JPY 537.93B 33.28B Mar/2026
BioCryst Pharmaceuticals USD 406.56M 247.16M Dec/2025
BioMarin Pharmaceutical USD 766M 109M Mar/2026
Celltrion KRW 1.15T 180B Mar/2026
Cspc Pharmaceutical CNY 6.11B 502.75M Dec/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Esperion Therapeutics USD 168.45M 81.14M Dec/2025
Exelixis USD 610.8M 12.14M Mar/2026
Halozyme Therapeutics USD 377M 74.76M Mar/2026
Ionis Pharmaceuticals USD 246M 43M Mar/2026
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Medical Developments International AUD 21.57M 12.04M Dec/2025
Moderna USD 389M 289M Mar/2026
Nektar Therapeutics USD 21.81M 2.32M Dec/2025
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Neurocrine Biosciences USD 811M 5.5M Mar/2026
Novartis USD 13.11B 226M Mar/2026
OPKO Health USD 148.45M 3.22M Dec/2025
Organigram Holdings CAD 63.54M 16.52M Dec/2025
Pfizer USD 14.5B 3.08B Mar/2026
Pharma Mar EUR 42.9M 47.3M Mar/2026
PTC Therapeutics USD 273M 108.3M Mar/2026
Qiagen NV USD 419.22M 38.16M Mar/2026
Regeneron Pharmaceuticals USD 3.6B 280M Mar/2026
Roche Holding CHF 15.65B 274.5M Dec/2025
Sarepta Therapeutics USD 730.8M 287.9M Mar/2026
Sartorius EUR 899.1M 28.5M Mar/2026
Sino Biopharmaceutical CNY 14.26B 3.31B Dec/2025
Tilray USD 217.51M 74.75M Dec/2025
Ultragenyx Pharmaceutical USD 136M 71M Mar/2026
Vertex Pharmaceuticals USD 2.99B 200M Mar/2026
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026